In metastatic breast cancer patients, we reported that a high level of TIMP-1 in the primary tumor tissue is associated with decreased objective response to chemotherapy [6], and a report showing a similar association in the adjuvant setting was recently presented [7]. The gene discussed is TIMP1; the disease is neoplasm.